|
시장보고서
상품코드
2055329
혈액 배양 검사 시장 : 검사법별, 제품별, 기술별, 용도별, 최종사용자별, 지역별Blood Culture Test Market, By Method, By Product, By Technology, By Application, By End User, By Geography |
||||||
혈액 배양 검사 시장은 2026년 72억 9,000만 달러로 추정되며, 2033년까지 156억 2,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 11.5%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 72억 9,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 11.50% | 2033년 시장 규모 예측 : | 156억 2,000만 달러 |
세계 혈액 배양 검사 시장은 진단 의료 업계의 중요한 부문으로, 혈류 감염, 패혈증, 균혈증을 검출하고 확인하기 위한 기반이 되고 있습니다.
혈액 배양 검사에서는 환자에게서 혈액 검체를 채취하여 전용 배지에서 배양함으로써, 혈류 내에서 순환하고 있을 가능성이 있는 세균, 진균, 효모 등의 병원성 미생물의 존재를 확인합니다. 이 조사 기법은 기술의 발전에 따라 크게 진화하여, 기존의 수동 방식에서 정밀도 향상, 결과 도출 시간 단축, 그리고 임상 결과 개선을 실현하는 자동화 시스템으로 전환되고 있습니다.
이 시장에는 기존의 배양법, 자동 혈액 배양 시스템, 분자진단 기술 등 다양한 조사 기법이 포함되어 있습니다. 적절한 항생제 치료법 선택과 환자 관리 전략에 필수적인 정보를 제공하기 위해, 전 세계 의료 기관들은 혈액 배양 검사에 크게 의존하고 있습니다.
병원 내 감염 증가, 패혈증 조기 진단에 대한 인식 제고, 그리고 항생제 적정 사용 프로그램에 대한 관심 증가로 인해, 혈액 배양 검사는 현대 의료에서 없어서는 안 될 도구로서의 위상을 확고히 하고 있습니다. 이 시장에는 진단실험실, 병원, 혈액은행, 연구소 등 다양한 이해관계자가 포함되어 있으며, 이들 모두 신뢰성 높고 효율적인 혈액 배양 검사 솔루션에 대한 수요 증가에 기여하고 있습니다.
시장 역학
세계 혈액 배양 검사 시장의 성장은 그 성장 궤도를 전반적으로 뒷받침하는 몇 가지 강력한 요인들에 의해 주도되고 있습니다. 주요 원인은 전 세계적으로 증가하고 있는 혈류 감염 및 패혈증 발생률이며, 이로 인해 신속하고 정확한 진단 솔루션에 대한 수요가 높아지고 있습니다. 병원 내 감염 증가에 더해, 암 치료, 장기 이식, 만성 질환으로 인한 면역 결핍 환자 수가 늘어나면서 시장에 큰 수요를 창출하고 있습니다. 검출 시간 단축과 감도 향상을 실현하는 자동 혈액 배양 시스템의 기술적 진보는 중요한 성장의 촉매제가 되고 있습니다.
또한, 감염병에 취약한 고령 인구 증가와 외과 수술 건수 증가도 시장 성장에 기여하고 있습니다. 하지만 시장에는 몇 가지 제약도 존재합니다. 자동 혈액 배양 시스템과 그 유지 관리에 드는 높은 비용은 자원이 한정된 의료 현장에서의 도입을 저해할 수 있습니다. 또한, 숙련된 검사 기사가 필요한 혈액 배양 절차의 복잡성과 오염으로 인한 위양성 결과의 위험도 또 다른 과제로 대두되고 있습니다. 진단 기기에 대한 엄격한 규제 요건과 기존 배양법이 시간이 오래 걸린다는 점도 시장 성장을 저해하는 요인이 될 수 있습니다.
그럼에도 불구하고, 며칠이 아닌 몇 시간 내에 결과를 도출할 수 있는 신속한 분자진단 기술 및 현장 진단 솔루션의 개발에는 큰 기회가 존재합니다. 신흥 시장의 의료 인프라 확충, 의료비 증가, 그리고 맞춤형 의료에 대한 관심 증가는 수익성이 높은 기회를 제공합니다. 해석 능력을 향상시키기 위한 인공지능(AI) 및 머신러닝 기술을 혈액 배양 시스템에 통합하고, 여러 병원체를 동시에 검출하기 위한 다중 검사 플랫폼을 개발하는 것은 시장 확대를 위한 유망한 방향을 제시하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 혈액 배양 검사 시장의 주요 기업 프로파일을 작성하였습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 혈액 배양 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업 및 금융 분석가를 포함한 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 혈액 배양 검사 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 혈액 배양 검사 시장 : 방법별, 2021년-2033년
제5장 세계의 혈액 배양 검사 시장 : 제품별, 2021년-2033년
제6장 세계의 혈액 배양 검사 시장 : 기술별, 2021년-2033년
제7장 세계의 혈액 배양 검사 시장 : 용도별, 2021년-2033년
제8장 세계의 혈액 배양 검사 시장 : 최종사용자별, 2021년-2033년
제9장 세계의 혈액 배양 검사 시장 : 지역별, 2021년-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
LSH 26.06.23Blood Culture Test Market is estimated to be valued at USD 7.29 Bn in 2026 and is expected to reach USD 15.62 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.29 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.50% | 2033 Value Projection: | USD 15.62 Bn |
The global blood culture test market represents a critical segment within the diagnostic healthcare industry, serving as a cornerstone for detecting and identifying bloodstream infections, sepsis, and bacteremia.
Blood culture testing involves the collection of blood samples from patients and their cultivation in specialized media to detect the presence of pathogenic microorganisms, including bacteria, fungi, and yeasts that may be circulating in the bloodstream. This diagnostic methodology has evolved significantly with technological advancements, transitioning from traditional manual methods to automated systems that offer enhanced accuracy, reduced time-to-results, and improved clinical outcomes.
The market encompasses various testing methodologies, including conventional culture methods, automated blood culture systems, and molecular diagnostic techniques. Healthcare facilities worldwide rely heavily on blood culture testing as it provides crucial information for appropriate antibiotic therapy selection and patient management strategies.
The increasing prevalence of hospital-acquired infections, rising awareness about early diagnosis of sepsis, and growing emphasis on antimicrobial stewardship programs have positioned blood culture testing as an indispensable tool in modern healthcare. The market includes various stakeholders such as diagnostic laboratories, hospitals, blood banks, and research institutions, all contributing to the expanding demand for reliable and efficient blood culture testing solutions.
Market Dynamics
The global blood culture test market growth is driven by several compelling factors that collectively propel its growth trajectory. The primary driver is the escalating incidence of bloodstream infections and sepsis globally, which has intensified the demand for rapid and accurate diagnostic solutions. The increasing prevalence of hospital-acquired infections, coupled with the growing number of immunocompromised patients due to cancer treatments, organ transplants, and chronic diseases, has created a substantial market demand. Technological advancements in automated blood culture systems, offering faster detection times and improved sensitivity, serve as significant growth catalysts.
Additionally, the growing geriatric population, which is more susceptible to infections, and the increasing number of surgical procedures contribute to market growth. However, the market faces certain restraints including the high cost of automated blood culture systems and their maintenance, which can limit adoption in resource-constrained healthcare settings. The complexity of blood culture procedures requiring skilled laboratory personnel and the risk of contamination leading to false-positive results pose additional challenges. Stringent regulatory requirements for diagnostic devices and the time-consuming nature of traditional culture methods can also impede market growth.
Nevertheless, significant opportunities exist in the development of rapid molecular diagnostic techniques and point-of-care testing solutions that can deliver results within hours rather than days. The expansion of healthcare infrastructure in emerging markets, increasing healthcare expenditure, and the growing focus on personalized medicine present lucrative opportunities. The integration of artificial intelligence and machine learning in blood culture systems for enhanced interpretation and the development of multiplex testing platforms for simultaneous detection of multiple pathogens represent promising avenues for market expansion.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global blood culture test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Becton, Dickinson and Company (BD), bioMerieux S.A., Thermo Fisher Scientific Inc., Danaher Corporation, Roche Diagnostics, Siemens Healthineers AG, Abbott Laboratories, Bruker Corporation, T2 Biosystems Inc., Cepheid Inc., Luminex Corporation, Merck KGaA (MilliporeSigma), Sartorius AG, QIAGEN N.V., and BioFire Diagnostics LLC
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global blood culture test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood culture test market
Market Segmentation
- Method Insights (Revenue, USD Bn, 2021 - 2033)
- Automated Blood Culture
- Conventional/Manual Blood Culture
- Product Insights (Revenue, USD Bn, 2021 - 2033)
- Consumables (e.g., Media, Assay kits and reagents, accessories, etc.)
- Instruments (Automated blood culture systems, laboratory equipment)
- Software and Services
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Culture-Based Technologies (including conventional, resin-based)
- Molecular Technologies (NAAT, PCR-based panels, Microarrays)
- Proteomic Technologies (MALDI-TOF, LC-MS)
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Bacterial Infections (e.g., bacteremia, septicemia)
- Fungal Infections (e.g., fungemia)
- Mycobacterial Infections
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Laboratories
- Diagnostic Laboratories
- Academic and Research Institutes
- Others (Pathology labs, Bacteriological labs, independent research labs, ambulatory surgery centers)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Becton, Dickinson and Company (BD)
- bioMerieux S.A.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Roche Diagnostics
- Siemens Healthineers AG
- Abbott Laboratories
- Bruker Corporation
- T2 Biosystems Inc.
- Cepheid Inc.
- Luminex Corporation
- Merck KGaA (MilliporeSigma)
- Sartorius AG
- QIAGEN N.V.
- BioFire Diagnostics LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Blood Culture Test Market, By Method
- Global Blood Culture Test Market, By Product
- Global Blood Culture Test Market, By Technology
- Global Blood Culture Test Market, By Application
- Global Blood Culture Test Market, By End User
- Global Blood Culture Test Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Blood Culture Test Market, By Method, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Automated Blood Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Conventional/Manual Blood Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Blood Culture Test Market, By Product, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Consumables (e.g., Media, Assay kits and reagents, accessories, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Instruments (Automated blood culture systems, laboratory equipment)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Blood Culture Test Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Culture-Based Technologies (including conventional, resin-based)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Molecular Technologies (NAAT, PCR-based panels, Microarrays)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Proteomic Technologies (MALDI-TOF, LC-MS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Blood Culture Test Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Bacterial Infections (e.g., bacteremia, septicemia)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fungal Infections (e.g., fungemia)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Mycobacterial Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Blood Culture Test Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Pathology labs, Bacteriological labs, independent research labs, ambulatory surgery centers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Blood Culture Test Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Becton, Dickinson and Company (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- bioMerieux S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bruker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- T2 Biosystems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cepheid Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Luminex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA (MilliporeSigma)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioFire Diagnostics LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
